Clinical trial Recruiting at 18 sites Observational Ages 18 and up

Monitoring complex renal cysts to compare surgery and active surveillance

Official title: Surveillance of Complex Renal Cysts - The SOCRATIC Study

Run by Université de Sherbrooke · NCT04558593 · Data updated 2026-11-12

This study is testing whether watching and monitoring complex kidney cysts is as safe and effective as surgery for patients with certain types of cysts.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment330 (estimated)
SponsorUniversité de Sherbrooke
Academic / other
Locations18 sites (Calgary, Alberta and 17 other locations)
StatusRecruiting
StartedFebruary 2, 2021
Main results expectedDecember 20, 2029
Study endsSeptember 20, 2031
Registry record updatedJune 1, 2026
Trial IDNCT04558593 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with newly diagnosed Bosniak III or IV cysts who are asymptomatic and have a life expectancy of more than five years.

Probably not a fit

Patients with a history of hereditary renal cancer syndromes or those with uncontrolled medical illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational study aims to evaluate the long-term outcomes of active surveillance versus surgical intervention for patients diagnosed with Bosniak III and IV renal cysts. The study will follow patients over a five-year period to compare cancer-specific survival rates, disease progression, and overall patient well-being between the two management strategies. Participants will choose their management approach and will be monitored through standard care visits. The study seeks to provide evidence on the safety and efficacy of active surveillance as an alternative to surgery for these complex cysts.

Why it matters

Potential benefit: If successful, this study could reduce unnecessary surgeries and associated complications for patients with benign renal cysts.

How similar studies have gone: Previous studies have suggested that active surveillance may be a viable option for managing complex renal cysts, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years old and older;
* diagnosed with a Bosniak III or IV cyst (classification 2019);
* size of cystic component ≤7cm;
* cyst wall/septum nodule (obtuse margin of protrusion) \<10mm (perpendicular axis) or nodular/solid component ≤2 cm in any axis;
* life expectancy \>5 years (by physician's estimate);
* new diagnosis ≤ 12 months from accrual date;
* currently asymptomatic from the disease;
* deemed fit enough for surgery;
* willingness and ability to complete questionnaires in either French or English;
* able and willing to provide informed consent

Exclusion Criteria:

* history of a hereditary renal cancer syndrome;
* presence of polycystic kidney disease;
* any prior history of RCC;
* received systemic therapy for another malignancy within the 12 months prior to accrual;
* uncontrolled medical illness including infections, hypertension, arrhythmias, heart failure, or myocardial infarction/unstable angina within 6 months that would predispose to immediate surgical therapy;
* metastatic disease or evidence of vascular or nodal disease;
* unwillingness to undergo monitoring and imaging studies;
* any contra-indication(s) to contrast-enhanced imaging (estimated glomerular filtration rate \<30min/mL)

Where it's running

  • Prostate Cancer Center
    Calgary, Alberta, Canada
    Recruiting
  • Northern Alberta Urology Center
    Edmonton, Alberta, Canada
    Recruiting
  • Vancouver Prostate Centre
    Vancouver, British Columbia, Canada
    Recruiting
  • Mens Health Clinic
    Winnipeg, Manitoba, Canada
    Recruiting
  • Nova Scotia Health Authority
    Halifax, Nova Scotia, Canada
    Recruiting
  • St-Joseph's Hospital
    Hamilton, Ontario, Canada
    Recruiting
Show 12 more locations
  • The Ottawa Hospital
    Ottawa, Ontario, Canada
    Recruiting
  • Thunder Bay Health Sciences Center
    Thunder Bay, Ontario, Canada
    Recruiting
  • Princess Margaret Hospital
    Toronto, Ontario, Canada
    Recruiting
  • Woodstock hospital
    Woodstock, Ontario, Canada
    Recruiting
  • Centre intégré de santé et de services sociaux de Chaudière-Appalaches - Hôtel-Dieu de Lévis
    Lévis, Quebec, Canada
    Recruiting
  • Chum
    Montreal, Quebec, Canada
    Recruiting
  • Hôpital Maisonneuve-Rosemont (CISSS-EIMtl)
    Montreal, Quebec, Canada
    Recruiting
  • McGill University Health Centre
    Montreal, Quebec, Canada
    Recruiting
  • CHU de Québec - Université Laval
    Québec, Quebec, Canada
    Recruiting
  • Centre de recherche du Centre hospitalier Universitaire de Sherbrooke
    Sherbrooke, Quebec, Canada
    Recruiting
  • CIUSSS Mauricie-Centre-du-Québec
    Trois-Rivières, Quebec, Canada
    Recruiting
  • CHU Bordeaux (URO-CCR)
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.